Genetics and genomics of asthma and allergic diseases

Immunological Reviews

Volumn 190, Issue , 2002, Pages 195-206

  Cookson, William ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; INTERLEUKIN 4;

ALLERGIC DISEASE; ASTHMA; ATOPIC DERMATITIS; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME 20P; CHROMOSOME 3Q; CHROMOSOME 5Q; CHROMOSOME ANALYSIS; DNA MODIFICATION; GENE CLUSTER; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENOMICS; LEPROSY; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; REVIEW;

ALLERGENS; ASTHMA; DERMATITIS, ATOPIC; FEMALE; GENOMIC IMPRINTING; GENOMICS; HUMANS; HYGIENE; HYPERSENSITIVITY; LINKAGE (GENETICS); MALE;

EID: 0036951192     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2002.19015.x     Document Type: Review

References (177)

1. Palmer LJ, Burton PR, Faux JA, James AL, Musk AW, Cookson WO. Independent inheritance of serum immunoglobulin E concentrations and airway responsiveness. Am J Respir Crit Care Med 2000;161:1836-1843.
2. Coca AF, Cooke RA. On the phenomenon of hypersensitiveness. J Immunol 1923;8:163-182.
3. Cookson WO, Hopkin JM. Dominant inheritance of atopic immunoglobulin-E responsiveness. Lancet 1988;i:86-88.
4. Juhlin L, Johansson G, Bennich H, Hogman C, Thyresson N. Immunoglobulin E in dermatoses. Levels in atopic dermatitis anal urticaria. Arch Dermatol 1969;100:12-16.
5. Cox HE, et al. Association of atopic dermatitis to the β subunit of the high affinity immunoglobulin E receptor. Br J Dermatol 1998;138:182-187.
6. Bos J. Immunology of Atopic Dermatitis. Oxford: Blackwell Science, 2000.
7. Cox HE. Clinical and Genetic Aspects of Atopic Dermatitis. London: University of London, 1999.
8. Williams H, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999;103:125-138.
9. Turner H, Kinet JP. Signalling through the high-affinity IgE receptor FcεRI. Nature 1999;402:B24-B30.
10. Holt PG, Macaubas C, Stumbles PA, Sly PD. The role of allergy in the development of asthma. Nature 1999;402:B12-B17.
11. Duffy DL, Martin NG, Battistutta D, Hopper JL, Mathews JD. Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis 1990;142:1351-1358.
12. Lawrence S, et al. Genetic analysis of atopy and asthma as quantitative traits and ordered polychotomies. Ann Hum Genet 1994;58:359-368.
13. Holberg CJ, et al. Segregation analysis of physician-diagnosed asthma in Hispanic and non-Hispanic white families. A recessive component? Am J Respir Crit Care Med 1996;154:144-150.
14. Jenkins MA, Hopper JL, Giles GG. Regressive logistic modeling of familial aggregation for asthma in 7,394 population-based nuclear families. Genet Epidemiol 1997;14:317-332.
15. Riedler J, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001;358:1129-1133.
16. Larsen FS, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986;15:487-494.
17. Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993;28:719-723.
18. Collins FS, Patrinos A, Jordan E, Chakravarti A, Gesteland R, Walters L. New goals for the US Human Genome Project: 1998-2003. Science 1998;282:682-689.
19. Daniels SE, et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 1996;383:247-250.
20. Xu J, et al. Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: collaborative study on the genetics of asthma. Am J Hum Genet 2001;68:1437-1446.
21. Ober C, Tsalenko A, Parry R, Cox NJ. A second-generation genomewide screen for asthma-susceptibility alleles in a founder population. Am J Hum Genet 2000;67:1154-1162.
22. Wjst M, et al. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics 1999;58:1-8.
23. Hizawa N, et al. Genetic regulation of Dermatophagoides pteronyssinus-specific IgE responsiveness: a genome-wide multipoint linkage analysis in families recruited through 2 asthmatic sibs. Collaborative Study on the Genetics of Asthma (CSGA). J Allergy Clin Immunol 1998;102:436-442
24. Mathias RA, et al. Genome-wide linkage analyses of total serum IgE using variance components analysis in asthmatic families. Genet Epidemiol 2001;20:340-355.
25. Dizier MH, et al. Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med 2000;162:1812-1818.
26. Laitinen T, et al. A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. Nat Genet 2001;28:87-91.
27. Hakonarson H, et al. A major susceptibility gene for asthma maps to chromosome 14q24. Am J Hum Genet 2002;71:483-491.
28. Koppelman GH, et al. Genome-wide search for atopy susceptibility genes in Dutch families with asthma. J Allergy Clin Immunol 2002;109:498-506.
29. Haagerup A, Bjerke T, Schiotz PO, Binderup HG, Dahl R, Kruse TA. Asthma and atopy - a total genome scan for susceptibility genes. Allergy 2002;57:680-686.
30. Van Eerdewegh P, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002;418:426-430.
31. Moffatt MF, et al. Genetic linkage of T cell receptor α/δ complex to specific IgE responses. Lancet 1994;343:1597-1600.
32. Marsh DG, et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:1152-1156.
33. Barnes KC, et al. Linkage of asthma and total serum IgE concentration to markers on chromosome 12q: evidence from Afro-Caribbean and Caucasian populations. Genomics 1996;37:41-50.
34. Levine BB, Stember RH, Fontino M. Ragweed hayfever: genetic control and linkage to HLA haplotyes. Science 1972;178:1201-1203.
35. Marsh DG, Meyers DA, Bias WB. The epidemiology and genetics of atopic allergy. N Engl J Med 1981;305:1551-1559.
36. Young RP, Dekker JW, Wordsworth BP, Cookson WOCM. HLA-DR, HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994;24:431-439.
37. Moffatt MF, et al. Association between quantitative traits underlying asthma and the HLA- DRB1 locus in a family-based population sample. Eur J Hum Genet 2001;9:341-346.
38. Dekker JW, et al. Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy 1997;27:574-577.
39. Young RP, Barker RD, Pile KD, Cookson WO, Taylor AJ. The association of HLA-DR3 with specific IgE to inhaled acid anhydrides. Am J Respir Crit Care Med 1995;151:219-221.
40. Moffatt MF, Schou C, Faux JA, Cookson WO. Germline TCR-A restriction of immunoglobulin E responses to allergen. Immunogenetics 1997;46:226-230.
41. Moffatt MF, Cookson WO. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 1997;6:551-554.
42. Albuquerque RV et al. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin Exp Allergy 1998;28:578-584.
43. Chagani T, et al. Prevalence of tumor necrosis factor-α?and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma. Am J Respir Crit Care Med 1999;160:278-282.
44. Li Kam Wa TC, et al. Association between - 308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthma. Clin Exp Allergy 1999;29:1204-1208.
45. Noguchi E, et al. Association between TNFA polymorphism and the development of asthma in the Japanese population. Am J Respir Crit Care Med 2002;166:43-46.
46. Witte JS, Palmer LJ, O'Connor RD, Hopkins PJ, Hall JM. Relation between tumour necrosis factor polymorphism TNFα-308 and risk of asthma. Eur J Hum Genet 2002;10:82-85.
47. Winchester EC, Millwood IY, Rand L, Penny MA, Kessling AM. Association of the TNF-α-308 (G→A) polymorphism with self-reported history of childhood asthma. Hum Genet 2000;107:591-596.
48. Cookson WO, Sharp PA, Faux JA, Hopkin JM. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989;i:1292-1295.
49. Sandford AJ, et al. Localisation of atopy and β subunit of high-affinity IgE receptor (FcεRI) on chromosome 11q. Lancet 1993;341:332-334.
50. Shirakawa T, et al. Association between atopic asthma and a coding variant of Fc ε RI β in a Japanese population. Hum Mol Genet 1996;5:1129-1130.
51. Hill MR, et al. Fc ε RI-β polymorphism and risk of atopy in a general population sample. Br Med J 1995;311:776-779.
52. van Herwerden L, et al. Linkage of high-affinity IgE receptor gene with bronchial hyperreactivity, even in absence of atopy. Lancet 1995;346:1262-1265.
53. Lin S, Cicala C, Scharenberg A, Kinet J. The Fc (ε) RIβ subunit functions as an amplifier of Fc (ε) RIγ-mediated cell activation signals. Cell 1996;85:985-995.
54. Donnadieu E, Cookson WO, Jouvin MH, Kinet JP. Allergy-associated polymorphisms of the FcεRIβ subunit do not impact its two amplification functions. J Immunol 2000;165:3917-3922.
55. Eiberg H, Lind P, Mohr J, Nielsen LS. Linkage relationship between the human immunoglobulin E polymorphism and marker systems. Cytogenet Cell Genet 1985;40:622.
56. Wiltshire S, et al. A genome scan for loci influencing total serum immunoglobulin levels: possible linkage of IgA to the chromosome 13 atopy locus. Hum Mol Genet 1998;7:27-31.
57. Anderson GG, et al. Positive association to IgE levels and a physical map of the 13q14 atopy locus. Eur J Hum Genet 2002;10:266-270.
58. Oscier DG. Cytogenetic and molecular abnormalities in chronic lymphocytic leukaemia. Blood Rev 1994;8:88-97.
59. Kalachikov S, et al. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics 1997;42:369-377.
60. Mabuchi H, et al. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia. Cancer Res 2001;61:2870-2877.
61. Rosenwasser L, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995;25:74-78 [discussion, 95-96].
62. Graves PE, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000;105:506-513.
63. Leung T, Tang N, Chan I, Li A, Ha G, Lam C. A polymorphism in the coding region of interleukin-13 gene is associated with atopy but not asthma in Chinese children. Clin Exp Allergy 2001;31:1515-1521.
64. Noguchi E, et al. Haplotypes of the 5′ region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma. Hum Immunol 2001;62:1251-1257.
65. Howard T, et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 2001;25:377-384.
66. van der Pouw Kraan TC, et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1999;1:61-65.
67. Rioux J, et al. Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet 1998;63:1086-1094.
68. Chavanas S, et al. Localization of the Netherton Syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping. Am J Hum Genet 2000;66:914-921.
69. Chavanas S, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000;25:141-142.
70. Mägert HJ, et al. LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem 1999;274:21499-21502.
71. Walley AJ, et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001;29:175-178.
72. Ober C, et al. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet 1998;7:1393-1398.
73. Weskamp G, Kratzschmar J, Reid MS, Blobel CP. MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J Cell Biol 1996;132:717-726.
74. Millichip MI, Dallas DJ, Wu E, Dale S, McKie N. The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem Biophys Res Commun 1998;245:594-598.
75. Becker K, et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998;95:9979-9984.
76. Laval SH, et al. Whole-genome screening in ankylosing spondylitis. evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918-926.
77. Mansfield J, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterol 1994;106:637-642.
78. Hardwick L, et al. Genetic mapping of susceptibility loci in the genes involved in rheumatoid arthritis. J Rheumatol 1997;24:197-198.
79. Nakagawa Y, et al. Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13. Am J Hum Genet 1998;63:547-556.
80. Satsangi J, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996;14:199-202.
81. Duerr RH, et al. Linkage and association between inflammatory bowel disease and a locus on chromosome 12. Am J Hum Genet 1998;63:95-100.
82. Lee YA, et al. A major susceptibility locus for tropic dermatitis maps to chromosome 3q21. Nat Genet 2000;26:470-473.
83. Cookson WO, et al. Genetic linkage of childhood tropic dermatitis to psoriasis susceptibility loci. Nat Genet 2001;27:372-373.
84. Bradley M, Soderhall C, Luthman H, Wahlgren CF, Kockum I, Nordenskjold M. Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. Hum Mol Genet 2002;11:1539-1548.
85. Beyer K, et al. Evidence for linkage of chromosome 5q31-q33 and 13q12-q14 markers to tropic dermatitis. J Allergy Clin Immunol 1998;101:152.
86. Camp R. Psoriasis. In: Champion R, Burton J, Burns D, Breathnach S, eds. Textbook of Dermatology. Oxford: Blackwell Science, 1998:1589-1649.
87. Capon F, et al. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol 1999:112:32-35.
88. Tomfohrde J, et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994;264:1141-1145.
89. Trembath R, et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997;6:813-820.
90. Enlund F, et al. Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden. Eur J Hum Genet 1999;7:783-790.
91. Farber E, Nall M, Watson W. Natural history of psoriasis in 61 twin pairs. Arch Dermatol 1974;109:207-211.
92. Brandrup F, Hauge M, Henningsen K, Eriksen B. Psoriasis in an unselected series of twins. Arch Dermatol 1978;114:874-878.
93. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ('epidermal differentiation complex') on human chromosome 1q21. J Invest Dermatol 1996;106:989-992.
94. Hardas B, Zhao X, Zhang J, Longqing X, Stoll S, Elder J. Assignment of psoriasin to human chromosomal band 1q21: coordinate overexpression of clustered genes in psoriasis. J Invest Dermatol 1996;106:753-758.
95. Marshall D, Hardman MJ, Nield KM, Byrne C. Differentially expressed late constituents of the epidermal cornified envelope. Proc Natl Acad Sci USA 2001;98:13031-13036.
96. Lohman F, Medema J, Gibbs S, Ponec M, dPP, Backendorf C. Expression of the SPRR cornification genes is differentially affected by carcinogenic transformation. Exp Cell Res 1997;231:141-148.
97. Steinert PM, Marekov LN. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem 1995;270:17702-17711.
98. Markova NG, Marekov LN, Chipev CC, Gan SQ, Idler WW, Steinert PM. Profilaggrin is a major epidermal calcium-binding protein. Mol Cell Biol 1993;13:613-625.
99. Lee SC, Wang M, McBride OW, O'Keefe EJ, Kim IG, Steinert PM. Human trichohyalin gene is clustered with the genes for other epidermal structural proteins and calcium binding proteins at chromosomal locus 1q21. J Invest Dermatol 1993;100:65-68.
100. Libert F, et al. The δccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet 1998;7:399-406.
101. Ramoz N, Rueda LA, Bouadjar B, Favre M, Orth G. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 1999;112:259-263.
102. Morishita Y, et al. Possible influences of Staphylococcus aureus on atopic dermatitis - the colonizing features and the effects of staphylococcal enterotoxins. Clin Exp Allergy 1999;29:1110-1117.
103. Kuokkanen S, et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997;61:1379-1387.
104. Sawcer S, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996;13:464-468.
105. Jawaheer D, et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 2001;68:927-936.
106. Tosh K, et al. A region of chromosome 20 is linked to leprosy susceptibility in a South Indian population. J Infect Dis 2002;186:1190-1193.
107. Gaffney PM, et al. Genome screening in human systemic lupus erythematosus. results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 2000;66:547-556.
108. Tomic-Canic M, Komine M, Freedberg IM, Blumenberg M. Epidermal signal transduction and transcription factor activation in activated keratinocytes. J Dermatol Sci 1998;17:167-181.
109. Freedberg I, Tomic-Canic M, Komine M, Blumenberg M. Keratins and the keratinocyte activation cycle. J Invest Dermatol 2001;116:633-640.
110. Song PI, et al. Human keratinocytes express functional CD14 and Toll-like receptor 4. J Invest Dermatol 2002;119:424-432.
111. Ichikawa JK, et al. Interaction of Pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs. Proc Natl Acad Sci USA 2000;97:9659-9664
112. Belcher CE, et al. The transcriptional responses of respiratory epithelial cells to Bordetella pertussis reveal host defensive and pathogen counter-defensive strategies. Proc Natl Acad Sci USA 2000;97:13847-13852.
113. Donato R. S100. a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001;33:637-668.
114. Komada T, Araki R, Nakatani K, Yada I, Naka M, Tanaka T. Novel specific chemtactic receptor for S100L protein on guinea pig eosinophils. Biochem Biophys Res Commun 1996;220:871-874.
115. Jinquan T, et al. Psoriasin: a novel chemotactic protein. J Invest Dermatol 1996;107:5-10.
116. Watson PH, Leygue ER, Murphy LC. Psoriasin (S100A7). Int J Biochem Cell Biol 1998;30:567-571.
117. + human monocytes. Int Immunol 2000;12:1593-1604.
118. Yui S, Mikami M, Yamazaki M. Purification and characterization of the cytotoxic factor in rat peritoneal exudate cells: its identification as the calcium binding protein complex, calprotectin. J Leukoc Biol 1995;58:307-316.
119. Brandtzaeg P, Gabrielsen TO, Dale I, Muller F, Steinbakk M, Fagerhol MK. The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol 1995;371A:201-206.
120. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990;336:763-765.
121. Aguiar-Passeti T, Postol E, Sorg C, Mariano M. Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation. J Leukoc Biol 1997;62:852-858.
122. Brun JG, Ulvestad E, Fagerhol MK, Jonsson R. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scand J Immunol 1994;40:675-680.
123. Passey RJ, Xu K, Hume DA, Geczy CL. S100A: emerging functions and regulation. J Leukoc Biol 1999;66:549-556.
124. Lackmann M, et al. Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10. J Immunol 1993;150:2981-2991.
125. Cornish CJ, Devery JM, Poronnik P, Lackmann M, Cook DI, Geczy CL. S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J Cell Physiol 1996;166:427-437.
126. Hofmann MA, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901.
127. Cabral A, Voskamp P, Cleton-Jansen AM, South A, Nizetic D, Backendorf C. Structural organization and regulation of the small proline-rich family of cornified envelope precursors suggest a role in adaptive barrier function. J Biol Chem 2001;276:19231-19237.
128. De Heller-Milev M, Huber M, Panizzon R, Hohl D. Expression of small proline rich proteins in neoplastic and inflammatory skin diseases. Br J Dermatol 2000;143:733-740.
129. Djian P, Easley K, Green H. Targeted ablation of the murine involucrin gene. J Cell Biol 2000;151:381-388.
130. Koch PJ, et al. Lessons from loricrin-deficient mice. compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol 2000;151:389-400.
131. Komatsu N, et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 2002;118:436-443.
132. Wachter AM, Lezdey J. Treatment of atopic dermatitis with α1-proteinase inhibitor. Ann Allergy 1992;69:407-414.
133. Benson M, et al. DNA microarrays to study gene expression in allergic airways. Clin Exp Allergy 2002;32:301-308.
134. Kaufman HS, Hobbs JR. Immunoglobulin deficiencies in an atopic population. Lancet 1970;ii:1061-1063.
135. Ludviksson BR, Eiriksson TH, Ardal B, Sigfusson A, Valdimarsson H. Correlation between serum immunoglobulin A concentrations and allergic manifestations in infants. J Pediatr 1992;121:23-27.
136. Wills-Karp M, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-2261.
137. Kuperman DA, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 2002;8:885-889.
138. Walley AJ, Cookson WO. Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet 1996;33:689-692.
139. ISAAC. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-1232.
140. Crater SE, Platts-Mills TA. Searching for the cause of the increase in asthma. Curr Opin Pediatr 1998;10:594-599.
141. von Mutius E, Martinez FD, Fritzsch C, Nicolai T, Roell G, Thiemann HH. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med 1994;149:358-364.
142. Bjorksten B, et al. Prevalence of childhood asthma, rhinitis and eczema in Scandinavia and Eastern Europe. Eur Respir J 1998;12:432-437.
143. Svanes C, Jarvis D, Chinn S, Burney P. Childhood environment and adult atopy: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;103:415-420.
144. Hesselmar B, Aberg N, Aberg B, Eriksson B, Bjorksten B. Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy 1999;29:611-617.
145. Strachan DP. Hay fever, hygiene, and household size. Br Med J 1989;299:1259-1260.
146. von Mutius E, Martinez FD, Fritzsch C, Nicolai T, Reitmeir P, Thiemann HH. Skin test reactivity and number of siblings. Br Med J 1994;308:692-695.
147. Holt PG, McMenamin C, Nelson D. Primary sensitisation to inhalant allergens during infancy. Pediatr Allergy Immunol 1990;1:3-15.
148. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990;323:502-507.
149. Holt PG, Sly PD, Bjorksten B. Atopic versus infectious diseases in childhood, a question of balance? Pediatr Allergy Immunol 1997;8:53-58.
150. Rook GA, Stanford JL. Give us this day our daily germs. Immunol Today 1998;19:113-116.
151. Sartono E, Kruize YC, Kurniawan A, Maizels RM, Yazdanbakhsh M. In Th2-biased lymphatic filarial patients, responses to purified protein derivative of Mycobacteriurn tuberculosis remain Th1. Eur J Immunol 1996;26:501-504.
152. Lacour M. Acute infections in atopic dermatitis. a clue for a pathogenic role of a Th1/Th2 imbalance? Dermatology 1994;188:255-257.
153. Winton HL, et al. Class specific inhibition of house dust mite proteinases which cleave cell adhesion, induce cell death and which increase the permeability of lung epithelium. Br J Pharmacol 1998;124:1048-1059.
154. Ring PC, Wan H, Schou C, Kroll Kristensen A, Roepstorff P, Robinson C. The 18-kDa form of cat allergen Felis domesticus 1 (Fel d 1) is associated with gelatin- and fibronectin-degrading activity. Clin Exp Allergy 2000;30:1085-1096.
155. Bufe A, Schramm G, Keown MB, Schlaak M, Becker WM. Major allergen Ph1 p Vb in timothy grass is a novel pollen RNase. FEBS Lett 1995;363:6-12.
156. Nagata S, Glovsky MM. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation. J Allergy Clin Immunol 1987;80:24-32.
157. Karp CL, et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol 2000;1:221-226
158. Matzinger P. The danger model. a renewed sense of self. Science 2002;296:301-305.
159. Stumbles PA, et al. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998;188:2019-2031.
160. Moffatt M, Cookson W. The genetics of asthma. Maternal effects in atopic disease. Clin Exp Allergy 1998;28:56-61 [discussion, 65-66].
161. Bennett S, Todd J. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet 1996;30:343-370.
162. Warram JH, Krolewski AS, Gottlieb MS, Kahn CR. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984;311:149-152.
163. Koumantaki Y, et al. Family history as a risk factor for rheumatoid arthritis: a case-control study. J Rheumatol 1997;24:1522-1526.
164. Burden A, Javed S, Bailey M, Hodgins M, Connor M, Tillman D. Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p. J Invest Dermatol 1998;110:958-960.
165. Akolkar PN, et al. Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease. Am J Gastroenterol 1997;92:2241-2244.
166. Vorechovsky I, Webster AD, Plebani A, Hammarstrom L. Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet 1999;64:1096-1109.
167. Hall JG. Genomic imprinting. Arch Dis Child 1990;65:1013-1016.
168. Reik W, Walter J. Genomic imprinting. parental influence on the genome. Nat Rev Genet 2001;2:21-32.
169. Lemke H, Lange H. Is there a maternally induced immunological imprinting phase a la Konrad Lorenz? Scand J Immunol 1999;50:348-354.
170. Lemke H, Lange H. Generalization of single immunological experiences by idiotypically mediated clonal connections. Adv Immunol 2002;80:203-241.
171. Ono Y, Sasaki T, Ishida N. Regulation of clonal development of immune responding cells by antibody of maternal origin. Nature 1974;250:593-594.
172. Stern CM. The materno-foetal transfer of carrier protein sensitivity in the mouse. Immunology 1976;30:443-448.
173. Jarrett EE, Hall E. IgE suppression by maternal IgG. Immunology 1983;48:49-58.
174. Jarrett E, Hall E. Selective suppression of IgE antibody responsiveness by maternal influence. Nature 1979;280:145-147.
175. Cookson WO, et al. Maternal inheritance of atopic IgE responsiveness on chromosome 11q. Lancet 1992;340:381-384.
176. Chess A. Expansion of the allelic exclusion principle? Science 1998;279:2067-2068.
177. Mostoslavsky R, et al. Asynchronous replication and allelic exclusion in the immune system. Nature 2001;414:221-225.